Published in Urology on December 04, 2006
2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation. Eur Radiol (2008) 0.81
Reconstruction of the abdominal vagus nerve using sural nerve grafts in canine models. PLoS One (2013) 0.79
Interpositional Nerve Grafting of the Prostatic Plexus after Radical Prostatectomy. Plast Reconstr Surg Glob Open (2015) 0.75
NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw (2010) 5.98
Surgery versus non-surgical therapy for carpal tunnel syndrome: a randomised parallel-group trial. Lancet (2009) 4.05
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci U S A (2011) 3.54
Stop using arbitrary grading schemes in carpal tunnel syndrome. Muscle Nerve (2008) 2.68
PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol (2008) 2.63
NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw (2009) 2.40
NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw (2010) 2.31
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology (2007) 2.14
Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 2.06
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (2004) 2.04
Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol (2007) 1.99
Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol (2003) 1.98
Sonographic diagnosis of true neurogenic thoracic outlet syndrome. Neurology (2013) 1.97
Detection and isolation of prostate cancer cells from peripheral blood and bone marrow. Urology (2003) 1.94
NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw (2009) 1.86
Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol (2010) 1.86
Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol (2010) 1.73
Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence. Clin Cancer Res (2009) 1.69
Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport (2003) 1.67
Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer (2006) 1.67
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
Point: open radical prostatectomy should not be abandoned. J Natl Compr Canc Netw (2007) 1.55
Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study. J Urol (2010) 1.53
A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. Scand J Urol Nephrol (2010) 1.48
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin Exp Metastasis (2007) 1.41
Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. Cancer Res (2005) 1.39
Controversies in the surgical management of renal cancer. J Natl Compr Canc Netw (2005) 1.37
Bladder cancer. J Natl Compr Canc Netw (2009) 1.32
Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. Cancer Res (2008) 1.32
Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer. Clin Genitourin Cancer (2006) 1.29
Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. J Urol (2008) 1.23
Improved prostate cancer detection with anterior apical prostate biopsies. Urol Oncol (2006) 1.19
Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes. BMC Cancer (2009) 1.19
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol (2010) 1.17
Resection of a benign brachial plexus nerve sheath tumor using intraoperative electrophysiological monitoring. Neurosurgery (2007) 1.13
CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Mod Pathol (2010) 1.11
Detection and characterization of circulating and disseminated prostate cancer cells. Front Biosci (2007) 1.10
Newer potential biomarkers in prostate cancer. Rev Urol (2007) 1.09
Imaging of peripheral nerve tumors. Neurosurg Focus (2007) 1.09
The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol (2011) 1.08
High-resolution magnetic resonance imaging is a noninvasive method of observing injury and recovery in the peripheral nervous system. Neurosurgery (2003) 1.08
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series. J Bone Miner Res (2013) 1.07
The relationship between electrodiagnostic findings and patient symptoms and function in carpal tunnel syndrome. Arch Phys Med Rehabil (2007) 1.06
Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer. Clin Cancer Res (2004) 1.06
Peroneal intraneural ganglia: the importance of the articular branch. Clinical series. J Neurosurg (2003) 1.05
Microscale surgery on single axons. Neurosurgery (2005) 1.04
Bladder cancer. Clinical guidelines in oncology. J Natl Compr Canc Netw (2006) 1.04
Magnetic resonance imaging anatomy of the female genitalia in premenopausal and postmenopausal women. J Urol (2003) 1.03
Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer. J Med Internet Res (2010) 1.03
Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4. Chem Biol (2009) 1.03
The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening. Prostate (2006) 1.01
Autonomic nervous system changes in men with chronic pelvic pain syndrome. J Urol (2007) 1.01
Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2. Mol Cancer Res (2008) 1.01
The clinico-anatomic explanation for tibial intraneural ganglion cysts arising from the superior tibiofibular joint. Skeletal Radiol (2006) 1.00
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15. Clin Cancer Res (2007) 1.00
The utility of magnetic resonance imaging in evaluating peripheral nerve disorders. Muscle Nerve (2002) 1.00
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate (2005) 0.99
Magnetic resonance imaging compared with electrodiagnostic studies in patients with suspected carpal tunnel syndrome: predicting symptoms, function, and surgical benefit at 1 year. J Neurosurg (2008) 0.98
Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. Biochemistry (2003) 0.98
Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw (2015) 0.98
In vivo use of a nanoknife for axon microsurgery. Neurosurgery (2007) 0.96
Telomerase activity in disseminated prostate cancer cells. BJU Int (2006) 0.95
Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine. Prostate (2011) 0.95
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. J Neurochem (2004) 0.94
Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer. Prostate (2007) 0.94
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation. J Clin Endocrinol Metab (2013) 0.93
What's new in MRI of peripheral nerve entrapment? Neurosurg Clin N Am (2008) 0.93
Cystoprostatectomy and neobladder construction for florid cystitis glandularis. Urology (2005) 0.92
Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls. Eur Urol (2012) 0.92
Prostate cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 0.92
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 0.92
Bladder cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2005) 0.91
Randomized clinical trial of surgery versus conservative therapy for carpal tunnel syndrome [ISRCTN84286481]. BMC Musculoskelet Disord (2005) 0.91
Intense focused ultrasound can reliably induce sensations in human test subjects in a manner correlated with the density of their mechanoreceptors. Ultrasound Med Biol (2011) 0.90
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. Prostate (2013) 0.89
Role of post-chemotherapy surgery in germ cell tumors. Urol Clin North Am (2007) 0.89
High-resolution ultrasonography and diffusion tensor tractography map normal nerve fascicles in relation to schwannoma tissue prior to resection. J Neurosurg (2014) 0.89
Regulated expression of active biotinylated G-protein coupled receptors in mammalian cells. Protein Expr Purif (2007) 0.89
Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study. Int Braz J Urol (2010) 0.89
Single cell transcriptomic analysis of prostate cancer cells. BMC Mol Biol (2013) 0.89
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence. Clin Cancer Res (2008) 0.88
Cutaneous corpuscular receptors of the human glans clitoris: descriptive characteristics and comparison with the glans penis. J Sex Med (2013) 0.88
Childhood sexual trauma in women with interstitial cystitis/bladder pain syndrome: a case control study. Can Urol Assoc J (2011) 0.88
A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome. Neurourol Urodyn (2010) 0.87
Dual reinnervation of biceps muscle after side-to-side anastomosis of an intact median nerve and a damaged musculocutaneous nerve. J Neurosurg (2013) 0.86
Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis. Prostate (2009) 0.86
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer. Cancer (2010) 0.85
Evaluation of autonomic innervation of the clitoris and bulb. J Urol (2004) 0.85
Suprascapular intraneural ganglia and glenohumeral joint connections. J Neurosurg (2006) 0.84